Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You are currently being treated with a medication called sotatercept at the Mayo Pulmonary Hypertension Clinic
Who may not be able to join:
- You are not able to give your own informed consent to participate in the study (for example, due to a cognitive or mental health condition that affects decision-making ability)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Robert Frantz, M.D., Mayo Clinic
Phone: 507-255-2648
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
EmPHasis10 Questionnaire; Number of pulmonary hypertension vasodilator medications taken by a subject; Number of patients to have a change in dose of prostanoid medications; Number of patient hospitalizations; Number of patients to cease therapy sessions; Number of patients to discontinue prostanoid therapy; Number of patients with bleeding complications; Number of patients to develop Skin telangiectasias; Change in 6 min walk distance; Number of patients to have a change in hemodynamics; Change in Right Ventricular Systolic Pressure (RVSP); Right Ventricular Strain; Change in Right Ventricle...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.